Ovarian hyperstimulation syndrome: A clinical report on 4894 consecutive ART treatment cycles

Reproductive Biology and Endocrinology

Volumn 13, Issue 1, 2015, Pages

  Sousa, Mário ^a   Cunha, Mariana ^a   Teixeira da Silva, José ^a   Oliveira, Cristiano ^a   Silva, Joaquina ^a   Viana, Paulo ^a   Barros, Alberto ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Clinical and newborn outcomes; Embryological; Gonadotrophin releasing hormone agonist; ICSI; IVF; Ovarian hyperstimulation syndrome

Indexed keywords

BUSERELIN; CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GANIRELIX; RECOMBINANT FOLLITROPIN; FERTILITY PROMOTING AGENT;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; ECTOPIC PREGNANCY; FEMALE; FEMALE INFERTILITY; HOSPITALIZATION; HUMAN; INFERTILITY; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEWBORN DISEASE; OOCYTE MATURATION; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; UNSPECIFIED SIDE EFFECT; ADVERSE EFFECTS; CHEMICALLY INDUCED; IN VITRO FERTILIZATION; PREGNANCY; PREGNANCY OUTCOME;

BUSERELIN; CHORIONIC GONADOTROPIN; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDIES;

EID: 84935038298     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/s12958-015-0067-3     Document Type: Article

References (34)

1. Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas. Hum Reprod. 1997;12:1129-37.
2. The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90:S188-93.
3. Rizk B, Aboulghar M, Smitz J, Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997;3:255-66.
4. Delvigne A. Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS. Reprod Biomed Online. 2009;19:8-13.
5. Hansen AT, Kesmodel US, Hvas AM. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod. 2014;29:611-7.
6. Salomon O, Schiby G, Heiman Z, Avivi K, Sigal C, Levran D, Dor J, Itzchak Y. Combined jugular and subclavian vein thrombosis following assisted reproductive technology--new observation. Fertil Steril. 2009;92:620-5.
7. Edris F, Kerner CM, Feyles V, Leung A, Power S. Successful management of an extensive intracranial sinus thrombosis in a patient undergoing IVF: case report and review of literature. Fertil Steril. 2007;88:705. e9-14.
8. Jing Z, Yanping L. Middle cerebral artery thrombosis after IVF and ovarian hyperstimulation: a case report. Fertil Steril. 2011;95:2435. e13-5.
9. Memarzadeh MT. A fatal case of ovarian hyperstimulation syndrome with perforated duodenal ulcer. Hum Reprod. 2010;25:808-9.
10. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85:112-20.
11. Fauser BC, Diedrich K, Devroey P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008;14:1-14.
12. Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10:32. doi: 10.1186/1477-7827-10-32 .
13. Humaidan P, Kol S, Papanikolaou EG. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update. 2011;17:510-24.
14. Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaey H, Humaidan P, Nelson SM. Consistent high clinical pregancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentric study. Hum Reprod. 2013;28:2529-36.
15. Humaidan P, Alsbjerg B. GnRHa trigger or final oocyte maturation: is HCG trigger history? Reprod Biomed Online. 2014;29:274-80.
16. Courbiere B, Oborski V, Braunstein D, Desparoir A, Noizet A, Gamerre M. Obstetric outcome of women with in vitro fertilization pregnancies hospitalized for ovarian hyperstimulation syndrome: a case-control study. Fertil Steril. 2011;95:1629-32.
17. Schenker JG, Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril. 1978;30:255-68.
18. Rizk B, Aboulghar M. Classification, Pathophysiology and Management of Ovarian Hyperstimulation Syndrome. In: Brinsd PR, editor. A text Book of in vitro Fertilization and Assisted Reproduction. 2nd ed. New York, USA: The Parthenon Publishing Group; 1999. p. 131-51.
19. Huirne JA, Homburg R, Lambalk CB. Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod. 2007;22:2805-13.
20. Pinto F, Oliveira C, Cardoso MF, Teixeira da Silva J, Silva J, Sousa M, Barros A. Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes. Reprod Biol Endocrinol. 2009;7:5. doi: 10.1186/1477-7827-7-5 .
21. 2+ fluxes and oocyte cytoplasmic dislocation. Fertil Steril. 1995;64:770-6.
22. Vandervorst M, Liebaers I, Sermon K, Staessen C, De Vos A, Van de Velde H, Van Assche E, Joris H, Van Steirteghem A, Devroey P. Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. Hum Reprod. 1998;13:3169-76.
23. Gardner DK, Lane ML, Stevens J, Schlenker T, Schollcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73:1155-8.
24. Radesic B, Tremellen K. Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates. Hum Reprod. 2011;26:3437-42.
25. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A, Devroey P. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod. 2005;20:636-41.
26. Luke B, Brown MB, Morbeck DE, Hudson SB, Coddington CC, Stern JE. Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome. Fertil Steril. 2010;94:1399-404.
27. Whelan JG, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril. 2000;73:883-96.
28. Humaidan P, Bredkjaer HE, Westergaard LG, Andersen CY. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril. 2010;93:847-54.
29. Tummon I, Gavrilova-Jordan L, Allemand MC, Session D. Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review. Acta Obst Gynecol Scand. 2005;84:611-6.
30. Lee T-H, Liu C-H, Huang C-C, Wu Y-L, Shih Y-T, Ho H-N, Yang Y-S, Lee M-S. Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23:160-7.
31. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. GnRH antagonists are safer than agonists: an update of a Cochrane review. Hum Reprod Update. 2011;17:435.
32. Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod. 2000;15:1490-8.
33. Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, Garcia-Velasco JA. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol. Fertil Steril. 2014;101:1008-11.
34. Lee KH, Kim SH, Jee BC, Kim YJ, Suh CS, Kim KC, Suh CS, Kim KC, Lee WD. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome. Fertil Steril. 2010;93:2274-80.